OTCMKTS:SEOVF Sernova (SEOVF) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free SEOVF Stock Alerts $0.41 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$0.41▼$0.4350-Day Range$0.40▼$0.5152-Week Range$0.37▼$0.83Volume17,900 shsAverage Volume23,150 shsMarket Capitalization$124.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Sernova alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Sernova Stock (OTCMKTS:SEOVF)Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.Read More SEOVF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SEOVF Stock News HeadlinesMarch 11, 2024 | marketwatch.comSernova Names Nicholas Rossettos Interim CFOJanuary 29, 2024 | msn.comSernova reports anticipated 2024 milestonesMarch 28, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… November 27, 2023 | msn.comSernova gets FDA orphan drug, rare pediatric designations for hemophilia ANovember 14, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Tuesday (SVA)October 30, 2023 | finance.yahoo.comSernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint CongressSeptember 29, 2023 | finance.yahoo.comSernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual MeetingSeptember 7, 2023 | finance.yahoo.comSernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch DeviceMarch 28, 2024 | Porter & Company (Ad)AI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… September 5, 2023 | marketwatch.comSernova Appoints Cynthia Pussinen as Chief ExecutiveSeptember 5, 2023 | seekingalpha.comSernova appoints CEOJune 26, 2023 | markets.businessinsider.comSernova (SVA) Receives a Buy from H.C. WainwrightJune 22, 2023 | finance.yahoo.comSernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System™ During Oral Presentation at American Diabetes Association 83rd Scientific SessionsJune 16, 2023 | finance.yahoo.comSernova to Participate in Upcoming Truist Securities Cell Therapy SymposiumJune 15, 2023 | markets.businessinsider.comEchelon Wealth Partners Remains a Buy on Sernova (SVA)May 31, 2023 | finance.yahoo.comSernova Announces Executive Alignment and Appoints New Board ChairMay 8, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Monday (SVA)April 28, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Thursday (SVA)April 25, 2023 | finance.yahoo.comConcerned Shareholders of Sernova Corp. Wish to Thank All ShareholdersApril 10, 2023 | finance.yahoo.comSernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the MedApril 6, 2023 | finanznachrichten.deSernova Corp.: Sernova Responds to Dissident Shareholders' Misleading Statements and Provides Corporate UpdatesMarch 23, 2023 | finance.yahoo.comAdvance Notice Filed with Sernova Corp. for the Nomination of Two Director NomineesMarch 22, 2023 | finance.yahoo.comSernova Announces Abstract on First Cohort of its Phase 1/2 Study Involving Islet Allotransplantation into Pre-vascularized Cell Pouch™ Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions 2023March 2, 2023 | finance.yahoo.comSernova to Participate in Upcoming Roth and Oppenheimer Investor ConferencesJanuary 30, 2023 | marketwatch.comSernova Shares Climb After Study Update on System to Preserve Thyroid FunctionJanuary 30, 2023 | uk.news.yahoo.comSernova Announces Advancements with its Novel Cell Pouch System(TM) to Preserve Thyroid Function Following Total ThyroidectomyJanuary 30, 2023 | finance.yahoo.comSernova Announces Advancements with its Novel Cell Pouch System™ to Preserve Thyroid Function Following Total ThyroidectomySee More Headlines Receive SEOVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/18/2024Today3/28/2024Next Earnings (Estimated)6/12/2024Fiscal Year End10/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:SEOVF CUSIPN/A CIK1491434 Webwww.sernova.com Phone(519) 858-5184Fax519-858-5184EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-28,910,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-146.71% Return on Assets-114.00% Debt Debt-to-Equity RatioN/A Current Ratio3.23 Quick Ratio3.23 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.12 per share Price / Book3.42Miscellaneous Outstanding Shares303,410,000Free FloatN/AMarket Cap$124.52 million OptionableNot Optionable Beta1.18 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Philip M. Toleikis B.A.M.Sc., Ph.D., President, CTO, Director of Technology & DirectorMr. Christopher BarnesVice President of Investor RelationsDr. Frank Shannon M.D.Vice President of Clinical Development & Regulatory AffairsMs. Cynthia PussinenCEO & DirectorMr. Nicholas J. Rossettos CPA (Age 58)M.B.A., Interim Chief Financial Officer Mr. Douglas MaretChief Science OfficerDr. Modestus Obochi M.B.A.Ph.D., Chief Business OfficerMore ExecutivesKey CompetitorsKinnate BiopharmaNASDAQ:KNTEAntibe TherapeuticsOTCMKTS:ATBPDAnnovis BioNYSE:ANVSProMetic Life SciencesOTCMKTS:PFSCFCitius PharmaceuticalsNASDAQ:CTXRView All Competitors SEOVF Stock Analysis - Frequently Asked Questions How have SEOVF shares performed in 2024? Sernova's stock was trading at $0.5328 at the beginning of the year. Since then, SEOVF shares have decreased by 23.0% and is now trading at $0.4104. View the best growth stocks for 2024 here. Are investors shorting Sernova? Sernova saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 110,400 shares, a decline of 19.9% from the February 29th total of 137,900 shares. Based on an average trading volume of 47,100 shares, the short-interest ratio is currently 2.3 days. View Sernova's Short Interest. When is Sernova's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024. View our SEOVF earnings forecast. How were Sernova's earnings last quarter? Sernova Corp. (OTCMKTS:SEOVF) posted its quarterly earnings results on Monday, March, 18th. The company reported ($0.02) earnings per share for the quarter. How do I buy shares of Sernova? Shares of SEOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SEOVF) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeAI to Meet the Same Fate as EVs? Porter & CompanyGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.